Secondary malignancy

Statins linked to lower death risk in nasopharyngeal cancer survivors

Among five-year survivors of cancer behind the nose, 10-year survival was 89.1% in statin users versus 71.8% in non-users.Among five-year survivors of cancer behind the nose, 10-year survival was 89.1% in statin users versus 71.8% in non-users.